Bladder cancer detection using a peptide substrate of the 20S proteasome

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The FEBS Journal

• Publication date

  2016-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/febs.13786PMID 27326540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substrate specificity of human matriptase-2.

  2014cited by this paper
• Carfilzomib: A new proteasome inhibitor for relapsed or refractory multiple myeloma

  2013cited by this paper
• Drug combinations with proteasome inhibitors in antitumor therapy.

  2013cited by this paper
• A new proteinase 3 substrate with improved selectivity over human neutrophil elastase.

  2013cited by this paper
• The proteasome in health and disease.

  2012cited by this paper
• Three wavelength substrate system of neutrophil serine proteinases.

  2012cited by this paper
• Pegylated fluorescent peptides as substrates of proteolytic enzymes.

  2012cited by this paper
• Sub‐angstrom modeling of complexes between flexible peptides and globular proteins

  2010cited by this paper
• Highly specific substrates of proteinase 3 containing 3-(2-benzoxazol-5-yl)-l-alanine and their application for detection of this enzyme in human serum.

  2010cited by this paper
• NMR‐Guided Molecular Docking of a Protein–Peptide Complex Based on Ant Colony Optimization

  2010cited by this paper
• Simultaneous fluorescent monitoring of proteasomal subunit catalysis.

  2010cited by this paper
• Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasome.

  2010cited by this paper
• Chemical Tools To Study the Proteasome

  2009cited by this paper
• General method for rapid synthesis of multicomponent peptide mixtures.

  2009cited by this paper
• Immunological methods to quantify and characterize proteasome complexes: development and application.

  2008cited by this paper
• Homogeneous, bioluminescent proteasome assays.

  2008cited by this paper
• Limitations of SLLVY-AMC in calpain and proteasome measurements.

  2008cited by this paper
• Assessment of circulating proteasome chymotrypsin-like activity in plasma of patients with acute and chronic leukemias.

  2008cited by this paper
• Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma.

  2007cited by this paper
• Extracellular proteasome in the human alveolar space: a new housekeeping enzyme?

  2007cited by this paper
• High plasma proteasome levels are detected in patients with metastatic malignant melanoma

  2005cited by this paper
• The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle*

  2005cited by this paper
• Degradation-mediated protein quality control in the nucleus.

  2005cited by this paper
• Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin–proteasome system and onto human diseases and drug targeting*

  2005cited by this paper
• Urinalysis: a comprehensive review.

  2005cited by this paper
• Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.

  2005cited by this paper
• Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.

  2004cited by this paper
• Proteasomes and Molecular Chaperones : Cellular Machinery Responsible for Folding and Destruction of Unfolded Proteins

  2003cited by this paper
• The structure of the mammalian 20S proteasome at 2.75 A resolution.

  2002cited by this paper
• Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases.

  2002cited by this paper
• Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma.

  2002cited by this paper
• Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies

  2001cited by this paper
• Rapid degradation of a large fraction of newly synthesized proteins by proteasomes

  2000cited by this paper
• Isolation and characterization of two 20S proteasomes from the endoplasmic reticulum of rat liver microsomes.

  1999cited by this paper
• Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology.

  1999cited by this paper
• Proteasome inhibitors: valuable new tools for cell biologists.

  1998cited by this paper
• Contribution of Proteasomal β-Subunits to the Cleavage of Peptide Substrates Analyzed with Yeast Mutants*

  1998cited by this paper
• Cell Biology: A Laboratory Handbook

  1997cited by this paper
• Subunit arrangement in the human 20S proteasome.

  1997cited by this paper
• Sodium dodecyl sulfate (SDS) activation of the 20S proteasome in rat liver.

  1995cited by this paper
• Optimization of solid-phase synthesis of [Ala8]-dynorphin A

  1992cited by this paper
• Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery

  1991cited by this paper
• The multicatalytic proteinase of mammalian cells

  1989cited by this paper
• The multicatalytic proteinase of mammalian cells.

  1989cited by this paper
• Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome)

  1988cited by this paper
• Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates.

  1984cited by this paper
• On the size of the active site in proteases. I. Papain.

  1967cited by this paper

• Primed for Interactions: Investigating the Primed Substrate Channel of the Proteasome for Improved Molecular Engagement

  2024cites this paper
• Cyclic Peptidic Furin Inhibitors Developed by Combinatorial Chemistry

  2023cites this paper
• Synthetic peptide array on gold for the electrochemical assessment of the 20S proteasome activity and effect of inhibitory compounds

  2023cites this paper
• Chemical tools to monitor bladder cancer progression

  2022cites this paper
• Investigation of the P1′ and P2′ sites of IQF substrates and their selectivity toward 20S proteasome subunits

  2022cites this paper
• Non‐Proteasomal Urine Activity in Bladder Cancer

  2021cites this paper
• Elastolytic activity is associated with inflammation in bladder cancer.

  2021cites this paper
• A Peptidomimetic Fluorescent Probe to Detect the Trypsin β2 Subunit of the Human 20S Proteasome

  2020cites this paper
• Measuring redox effects on the activities of intracellular proteases such as the 20S Proteasome and the Immuno-Proteasome with fluorogenic peptides.

  2019cites this paper
• Selective Substrates and Activity-Based Probes for Imaging of the Human Constitutive 20S Proteasome in Cells and Blood Samples.

  2018cites this paper
• Screening Combinatorial Peptide Libraries in Protease Inhibitor Drug Discovery

  2018cites this paper
• Emerging challenges in the design of selective substrates, inhibitors and activity‐based probes for indistinguishable proteases

  2017cites this paper
• Novel internally quenched substrate of the trypsin-like subunit of 20S eukaryotic proteasome.

  2016cites this paper